Home Healthcare Biotechnology Gene Therapy Market

Gene Therapy Market Size, Share & Trends Analysis Report By Vector (Viral, Non-Viral), By Indication (Cancer, Cystic fibrosis, Heart diseases, Diabetes, Hemophiles, AIDS, Others), By Route of Administration (Intravenous, Inhalation) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Gene Therapy Market, By Vector 2022-2034 (USD MILLION/ Units)
    1. Viral
      1. AAV
      2. Lentiviral vectors
      3. Others
    2. Non-Viral
  2. Gene Therapy Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Cancer
    2. Cystic fibrosis
    3. Heart diseases
    4. Diabetes
    5. Hemophiles
    6. AIDS
    7. Others
  3. Gene Therapy Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Intravenous
    2. Inhalation
  4. Regional Gene Therapy Market
    1. North America
      1. North America Gene Therapy Market By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      2. North America Gene Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      3. North America Gene Therapy Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
      4. U.S.
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      5. Canada
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
    2. Europe
      1. Europe Gene Therapy Market By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      2. Europe Gene Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      3. Europe Gene Therapy Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
      4. U.K.
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      5. Germany
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      6. France
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      7. Spain
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      8. Italy
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      9. Russia
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      10. Nordic
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      11. Benelux
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      12. Rest of Europe
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
    3. APAC
      1. APAC Gene Therapy Market By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      2. APAC Gene Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      3. APAC Gene Therapy Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
      4. China
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      5. Korea
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      6. Japan
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      7. India
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      8. Australia
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      9. Singapore
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      10. Taiwan
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      11. South East Asia
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      12. Rest of Asia-Pacific
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
    4. Middle East and Africa
      1. Middle East and Africa Gene Therapy Market By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      2. Middle East and Africa Gene Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      3. Middle East and Africa Gene Therapy Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
      4. UAE
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      5. Turkey
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      6. Saudi Arabia
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      7. South Africa
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      8. Egypt
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      9. Nigeria
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      10. The rest of MEA
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
    5. LATAM
      1. LATAM Gene Therapy Market By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      2. LATAM Gene Therapy Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      3. LATAM Gene Therapy Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
      4. Brazil
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      5. Mexico
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      6. Argentina
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      7. Chile
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      8. Colombia
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
      9. Rest of LATAM
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
        3. Cancer
        4. Cystic fibrosis
        5. Heart diseases
        6. Diabetes
        7. Hemophiles
        8. AIDS
        9. Others
        10. Intravenous
        11. Inhalation
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.